Medicares coverage decision is considered pivotal to the future of Aduhelm, which is priced at $28,200 a year per patient. Roughly 80 percent of the patients eligible for the drug are old enough to r… [+1810 chars]
Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelm – The New York Times